Glenmark Pharmaceuticals has informed about submission of media release titled ‘Glenmark Pharmaceuticals receives ANDA approval for Sevelamer Hydrochloride Tablets, 400 mg and 800 mg’, which is self explanatory.
The above information is a part of company’s filings submitted to BSE.